Therapeutic areas

With the overall aim of increasing patient engagement to life-changing treatment and medication, our focus is on long-term conditions, cancer, and rare diseases.

Our mission is to give patients across Europe, control of their health through knowledge, choice, convenience and connection.

Rare diseases & orphan drugs

We’re a global network dedicated to getting rare and orphan medicines to hard-to-reach patients worldwide.

Long-term conditions

As a leading life sciences organisation, we help those with long-term conditions get the best from their medicines.

Cancer treatments

Delivering a range of treatments, we are the UK’s leading provider of cancer in-home care.

Sciensus Digital+

We elevate patient care by combining advanced digital platforms with a personalised “human touch”.

Our impact

As recognised experts with over 30 years’ experience, we continue to make a significant impact on the European markets in which we operate.

Delivering vital medicines

We make over 90,000 clinical deliveries every month across 50 therapy areas.

Cancer care at home

Our highly-trained nurses treat over 100 cancers via a wide range of therapies.

Increasing European access

In 2022 we supplied 250k units of medication for rare and ultra-rare diseases.

Powered by insight

Stay up to date with the news, find out more about our latest developments and learn from experts across Sciensus.

News

Sciensus Easter 2025 bank holiday opening hours

Ensuring a timely delivery of medication to patients is our priority and, with the Easter bank holiday just around the…

Thought Leadership

Leverage patient-reported data and PROMs to improve outcomes in oncology

Thought Leadership

Commercialization of rare & orphan products in Switzerland and smaller EU Markets